Tourette Syndrome in Children

4

Review clinical trials related to Tourette Syndrome in Children. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Study on the Mechanism of Pei Tu Ning Feng Tang in Alleviating Tourette Syndrome Via Functional Near-Infrared Spectroscopy (fNIRS) and the DA-MAPK-BDNF Pathway

Tourette Syndrome (TS) children were administered Pei Tu Ning Feng Tang treatment. The differences in gut microbiota composition, peripheral blood stress hormones, oxidative stress markers, cytokines, neurotransmitters, and hair cortisol concentrations were observed before and after treatment. Combined with the differences in tic-like behavioral indicators, the therapeutic efficacy of Pei Tu Ning Feng Tang was evaluated. Additionally, TS children underwent two fNIRS examinations before and after treatment to quantitatively describe the activation of brain function by Pei Tu Ning Feng Tang and to investigate its neural mechanisms against tics. Scores were assessed before and after treatment using the Yale Global Tic Severity Scale (YGTSS) and the Traditional Chinese Medicine Syndrome Score Sheet for Pediatric Tourette Syndrome (Spleen Deficiency and Liver Hyperactivity Type) to observe the efficacy of the medication.

Participants needed: 60
Trial details
Age: 4-15Biological sex: AllType: InterventionalSponsor: Dongdong QinUpdated: Feb 18, 2026
Eligibility criteria

Not listed

Status: Recruiting

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

There are currently no approved medications for the treatment of anxiety in children and youth with neurodevelopmental disorders (NDDs), both common and rare. Sertraline, a selective serotonin reuptake inhibitor, has extensive evidence to support its use in children's and youth with anxiety but not within NDDs. More research is needed to confirm whether or not sertraline could help improve anxiety in children and youth with common and rare neurodevelopmental conditions. This is a pilot study, in which we plan to estimate the effect size of reduction in anxiety of sertraline vs. placebo. across rare and common neurodevelopmental disorders, and determine the best measure(s) to be used as a primary transdiagnostic outcome measure of anxiety, as well as diagnosis specific measures in future, larger-scale clinical trials of anxiety in NDDs.

Participants needed: 130
Trial details
Phase: Phase 2Age: 8-17Biological sex: AllType: InterventionalSponsor: Holland Bloorview Kids Rehabilitation HospitalUpdated: Jul 16, 2025Locations: 8
Eligibility criteria

Outpatients 8-17 years of age, inclusive [+8]

Receiving other SSRIs within four weeks of randomization (6 weeks for fluoxetine... [+12]

Status: Recruiting

Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics

The primary aim of this study is to learn more about premonitory urges (PU) when using Habit Reversal Training (HRT) to treat tics. The main focus of this study is to investigate if and when PU change during tic treatment sessions and between tic treatment sessions. Participants will: * Attend 5 study visits (approximately 1 to 1.5 hours each) for an intake, habit reversal training for 3 separate tics, and a post assessment * Attend 5 practice sessions (approximately 30 minutes each) over a week for 3 weeks (total 15 practice sessions) * Study visits and practice sessions will take place in person and online via secure videoconference

Participants needed: 6
Trial details
Age: 8-17Biological sex: AllType: InterventionalSponsor: University of UtahUpdated: May 28, 2025Locations: 1
Eligibility criteria

present with at least three motor and/or vocal tics and are interested in receiv... [+4]

the presence of any comorbid conditions that are considered a primary treatment... [+3]

Status: Recruiting

The Findings of Magnetic Resonance Imaging in Subtypes of Tics-related Disorders

The findings of resting-state functional magnetic resonance imaging and diffusion spectrum imaging in subtypes of tics-related disorders

Participants needed: 500
Trial details
Age: 0-18Biological sex: AllType: ObservationalSponsor: National Taiwan University HospitalUpdated: Aug 6, 2024Locations: 1
Eligibility criteria

Age less than 18 years old [+1]

History of neuropsychiatric disorders [+2]